122 related articles for article (PubMed ID: 21623925)
1. Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test.
Silva LC; Geluk A; Arnone M; Romiti R; Franken KC; Duarte AJ; Takahashi MD; Benard G
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):319-24. PubMed ID: 21623925
[TBL] [Abstract][Full Text] [Related]
2. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
Silva LC; Silveira GG; Arnone M; Romiti R; Geluk A; Franken KC; Duarte AJ; Takahashi MD; Benard G
Arch Dermatol Res; 2010 May; 302(4):255-62. PubMed ID: 19609541
[TBL] [Abstract][Full Text] [Related]
3. Infliximab does not lead to reduction in the interferon-gamma and lymphoproliferative responses of patients with moderate to severe psoriasis.
Ortigosa LC; Silva LC; Duarte AJ; Takahashi MD; Benard G
Acta Derm Venereol; 2014 Jan; 94(1):26-31. PubMed ID: 23824243
[TBL] [Abstract][Full Text] [Related]
4. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting.
de Andrade Lima E; de Andrade Lima M; de Lorena VM; de Miranda Gomes Y; Lupi O; Benard G
Acta Derm Venereol; 2011 Oct; 91(6):694-7. PubMed ID: 21629971
[TBL] [Abstract][Full Text] [Related]
7. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
9. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
[TBL] [Abstract][Full Text] [Related]
11. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
Matulis G; Jüni P; Villiger PM; Gadola SD
Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
[TBL] [Abstract][Full Text] [Related]
12. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
13. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
[TBL] [Abstract][Full Text] [Related]
15. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
[TBL] [Abstract][Full Text] [Related]
16. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
[TBL] [Abstract][Full Text] [Related]
17. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
Bourgarit A; Carcelain G; Martinez V; Lascoux C; Delcey V; Gicquel B; Vicaut E; Lagrange PH; Sereni D; Autran B
AIDS; 2006 Jan; 20(2):F1-7. PubMed ID: 16511406
[TBL] [Abstract][Full Text] [Related]
18. The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays.
Vilaplana C; Ruiz-Manzano J; Gil O; Cuchillo F; Montané E; Singh M; Spallek R; Ausina V; Cardona PJ
Scand J Immunol; 2008 Jun; 67(6):610-7. PubMed ID: 18397200
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
[TBL] [Abstract][Full Text] [Related]
20. A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy.
Xie X; Chen JW; Li F; Tian J; Gao JS; Zhang D
Clin Exp Med; 2011 Sep; 11(3):155-61. PubMed ID: 21161670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
